Oxford BioMedica PLC (LSE:OXB)
£ 3.955 0.235 (6.32%) Market Cap: 416.69 Mil Enterprise Value: 445.59 Mil PE Ratio: 0 PB Ratio: 6.15 GF Score: 70/100

Half Year 2024 Oxford Biomedica PLC Earnings Call Transcript

Sep 23, 2024 / 12:30PM GMT
Release Date Price: £3.6 (+0.84%)
Frank Mathias
Oxford Biomedica PLC - Chief Executive Officer, Executive Director

Good afternoon, everyone and good morning to those on the other side of the ocean. Thank you for attending today's analyst briefing on our interim results for the 6 months ended June 30, 2024. It's always my pleasure to speak to you today for my first set of OXB results. It's also a great pleasure to see so many known faces, familiar faces here in the room, thank you for joining us. With me today, and I'm proud to say our newly appointed Chief Financial Officer, Lucy Crabtree, who many of you already know probably from the past and who joined us just 3 weeks ago, exactly 2 weeks ago, Lucy. We are very excited to have you on board, Lucy and as we embark on a very new or next chapter itself of our journey. And I will let Lucy introduce herself when we start her part in the presentation shortly. I'm also delighted to have our Chief Business Officer, Dr. Sebastien Ribault with us, whom you already know from the past, you will hear from both of them in due course throughout this presentation. Also with us in the room is Stuart

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot